Mycrodose Therapeutics Inc. is a U.S.-based pharmaceutical company headquartered in San Diego, California specializing in the development of advanced drug delivery systems utilizing DEA Schedule I & III drugs and other compounds to treat cancer related conditions, mental health, and cognitive degenerative diseases. Mycrodose's California laboratory includes a transdermal department with full in-vitro and analytical capacities that allows for all intellectual property and proprietary data to remain in-house. The company believes that its IP-Protected Sustained Microdosing Technology™ is a smarter and safer approach to delivering pharmaceutical compounds to patients of all ages and allows for an expandable and scalable business model.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 5940 Pacific Mesa Ct,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://mycrodosethera.com/
- Keywords
- Montreal.
- HQ
- San Diego, California
Mycrodose Therapeutics Questions
Mycrodose Therapeutics's website is https://mycrodosethera.com/
Mycrodose Therapeutics's LinkedIn profile is https://www.linkedin.com/company/mycrodose-therapeutics
Mycrodose Therapeutics has
3 employees.
View email and phone details for 3
employees at Mycrodose Therapeutics.
Mycrodose Therapeutics's industry is
Pharmaceutical Manufacturing
Mycrodose Therapeutics's top competitors are
R&d Therapeutics,
Alto Pharmacy,
Fsd Pharma Inc.,
Filtrous,
Tlc Therapeutics, Llc,
Mercanto (Tsx.v: Mush),
Phoebe Putney Memorial Hospital Inc,
Neural Therapeutics,
Lief Organics,
Nexi Biotech.
Mycrodose Therapeutics's categories are Pharmaceutical Manufacturing
Mycrodose Therapeutics's founding year is 2020
